Jul 15, 2018
The demand for Medical Cannabis is burgeoning. It shows promise for reducing opioid dependence, pain management and a host of other medical conditions. Pure Global Cannabis is at the forefront of this movement. It's subsidiary Puresinse has obtained a rare license from the Canadian government to produce and distribute medical cannabis and it has all the pieces in place to become a dominant international player. Most importantly is CEO Malay Panchal. A pharmacist by training, he has long been involved with major pharmaceutical companies, helping them to make full use of Internet technology. This opportunity came along and Malay jumped at it. How many times in life do you get the opportunity to be one of the first in an emerging industry? He's excited to be backed by major players in a brand new company that emerged on the scene via reverse merger. Pure Global Cannabis has just been listed on the TSX.V under the symbol PURE and FSN is thrilled to have a Pure sponsor.